These in vitro measurements predict a saturation concentration of urate in serum of 0 5 8 mmol/l (9 7 mg/100 ml) at 37°C which is a bit higher than the value of 0 4 mmol/l (7 mg/100 ml) usually taken as the critical concentration for the onset of gout. The concentrations achieved by the incubation of urate crystals with human serum are in the range of 0-3-0-5 mmol/l (6-8 mg/100 ml).5
This lower value compared to saline solutions probably reflects the effect of the non-electrolytes dissolved in serum.
Nucleation
Nucleation is easy to observe. One simply allows solutions to cool to a desired temperature and looks with a microscope for precipitates after suitable times have elapsed. The problem is that nucleation may readily be induced by small numbers of submicroscopic foreign particleswhich provide surfaces for heterogenous nucleation. The nucleating efficiency of various surfaces may be characterised by the degree of supersaturation at which they induce nucleation. Thus, according to the picture in Fig. 2 Fig. 4 studied this effect with neul serum albumin and a nun polymers. Addition of 33 neutral red to a 70 mmolI sodii solution increased the crysta time by a factor of 50. Serum at about 10 g/l, as in synovi increased the crystallisation ti factor of about 4, which is no effect (Fig. 4) We would like to thank the MRC for the support of RWF during this work.
